Víctor Segura-Jiménez1, Inmaculada C Álvarez-Gallardo2, Ana Carbonell-Baeza3, Virginia A Aparicio4, Francisco B Ortega2, Antonio J Casimiro5, Manuel Delgado-Fernández2. 1. Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain. Electronic address: vsegura@ugr.es. 2. Department of Physical Education and Sport, Faculty of Sport Sciences, University of Granada, Granada, Spain. 3. Department of Physical Education, Faculty of Education Sciences, University of Cádiz, Cádiz, Spain. 4. Department of Physiology, Faculty of Pharmacy, Faculty of Sport Sciences and Institute of Nutrition and Food Technology, University of Granada, Granada, Spain. 5. Department of Didactics for Language and Literature, Social Science and Physical and Sports Education, University of Almería, Almería, Spain.
Abstract
OBJECTIVES: To characterize a representative sample of fibromyalgia women based on a set of relevant factors known to be related to this disease. To distinguish specific factors of the disease from other symptoms that might also exist in non-fibromyalgia women. To test whether fibromyalgia affects more severely physical or psychological outcomes. METHODS: A total of 459 fibromyalgia women vs. 214 non-fibromyalgia (control) women from Southern Spain (Andalusia) took part in this cross-sectional study. Several instruments were used to assess tenderness, impact of fibromyalgia, fatigue, health-related quality of life, mental health, and cognitive performance. RESULTS: Overall, fibromyalgia women showed a worse status in pain, fatigue, health-related quality of life, depression, and anxiety than controls (P < 0.01). In general, the observed associations presented very large effect sizes (Cohen׳s d from ~1 to ~5.5). No differences between fibromyalgia and controls were observed in cognitive and memory performance, except for delayed recall, but the observed effect size was low (~0.25). The effect size observed for the global physical component (~3.3) was larger than that for the global psychological component (~1.3), all P < 0.001. CONCLUSIONS: Our results reinforce the understanding of fibromyalgia as a polysymptomatic distress condition with pain as its main symptom. Our findings support that fibromyalgia seems to have a greater impact on physical than on psychological outcomes, though both are largely affected.
OBJECTIVES: To characterize a representative sample of fibromyalgiawomen based on a set of relevant factors known to be related to this disease. To distinguish specific factors of the disease from other symptoms that might also exist in non-fibromyalgiawomen. To test whether fibromyalgia affects more severely physical or psychological outcomes. METHODS: A total of 459 fibromyalgiawomen vs. 214 non-fibromyalgia (control) women from Southern Spain (Andalusia) took part in this cross-sectional study. Several instruments were used to assess tenderness, impact of fibromyalgia, fatigue, health-related quality of life, mental health, and cognitive performance. RESULTS: Overall, fibromyalgiawomen showed a worse status in pain, fatigue, health-related quality of life, depression, and anxiety than controls (P < 0.01). In general, the observed associations presented very large effect sizes (Cohen׳s d from ~1 to ~5.5). No differences between fibromyalgia and controls were observed in cognitive and memory performance, except for delayed recall, but the observed effect size was low (~0.25). The effect size observed for the global physical component (~3.3) was larger than that for the global psychological component (~1.3), all P < 0.001. CONCLUSIONS: Our results reinforce the understanding of fibromyalgia as a polysymptomatic distress condition with pain as its main symptom. Our findings support that fibromyalgia seems to have a greater impact on physical than on psychological outcomes, though both are largely affected.
Authors: S Córdoba-Torrecilla; V A Aparicio; A Soriano-Maldonado; F Estévez-López; V Segura-Jiménez; I Álvarez-Gallardo; P Femia; M Delgado-Fernández Journal: Qual Life Res Date: 2015-09-08 Impact factor: 4.147
Authors: Pedro J Ruiz-Montero; C Paul Van Wilgen; Victor Segura-Jiménez; Ana Carbonell-Baeza; Manuel Delgado-Fernández Journal: Rheumatol Int Date: 2015-05-13 Impact factor: 2.631
Authors: Alberto Soriano-Maldonado; Kirstine Amris; Francisco B Ortega; Víctor Segura-Jiménez; Fernando Estévez-López; Inmaculada C Álvarez-Gallardo; Virginia A Aparicio; Manuel Delgado-Fernández; Marius Henriksen; Jonatan R Ruiz Journal: Qual Life Res Date: 2015-06-14 Impact factor: 4.147
Authors: Fernando Estévez-López; Cindy M Gray; Víctor Segura-Jiménez; Alberto Soriano-Maldonado; Inmaculada C Álvarez-Gallardo; Manuel J Arrayás-Grajera; Ana Carbonell-Baeza; Virginia A Aparicio; Manuel Delgado-Fernández; Manuel Pulido-Martos Journal: Qual Life Res Date: 2015-01-18 Impact factor: 4.147
Authors: Pedro Ángel Latorre-Román; Víctor Segura-Jiménez; Virginia A Aparicio; María Aparecida Santos E Campos; Felipe García-Pinillos; Manuel Herrador-Colmenero; Inmaculada C Álvarez-Gallardo; Manuel Delgado-Fernández Journal: Rheumatol Int Date: 2015-01-24 Impact factor: 2.631
Authors: Octavio Luque-Reca; Alberto Soriano-Maldonado; Blanca Gavilán-Carrera; Pedro Acosta-Manzano; Patrocinio Ariza-Vega; Gustavo A Reyes Del Paso; Inmaculada C Álvarez-Gallardo; Fernando Estévez-López Journal: Qual Life Res Date: 2022-01-31 Impact factor: 4.147
Authors: Ellen R Huang; Kim D Jones; Rob M Bennett; Gordon C Nagayama Hall; Karen S Lyons Journal: Psychol Health Med Date: 2018-02-23 Impact factor: 2.423
Authors: Fernando Estévez-López; Diego F Salazar-Tortosa; Daniel Camiletti-Moirón; Blanca Gavilán-Carrera; Virginia A Aparicio; Pedro Acosta-Manzano; Víctor Segura-Jiménez; Inmaculada C Álvarez-Gallardo; Ana Carbonell-Baeza; Diego Munguía-Izquierdo; Rinie Geenen; Eliana Lacerda; Manuel Delgado-Fernández; Luis J Martínez-González; Jonatan R Ruiz; María J Álvarez-Cubero Journal: J Clin Med Date: 2021-04-28 Impact factor: 4.241